You are here: Industry Insights > chronic disease

News List

Novel implantable polymer could improve controlled release of drugs europeanpharmaceuticalreview
May 26, 2021
Using piezoelectricity, electricity produced in response to mechanical stress, researchers have developed a novel controlled drug release system for the treatment of chronic conditions.
FibroGenesis Announces the Filing of its 250th Patent for Fibroblast Cell Therapy Platform prnasia
November 13, 2020
FibroGenesis, a Texas-based regenerative medicine company focused on tissue regeneration and chronic disease reversal using Human Dermal Fibroblasts (HDFs), announced the filing of its 250th patent related to its fibroblast cell therapy platform.
AI should be used to detect chronic disease, says PM pharmatimes
May 24, 2018
In a speech later today, the PM will challenge the NHS, industry and health charities to employ AI technologies able to sift through huge patient data sets to cross reference genetics, habits and medical records with national data in the hope of speeding
Biomedical Institute for global health research and Technology (BIGHEART) at NUS and Holmusk partner pharmaasia
April 18, 2017
The National University of Singapore and Holmusk signed a Memorandum of Understanding for improving healthcare delivery in the region.
Biomedical Institute for Global Health Research and Technology (BIGHEART) at NUS and Holmusk Partner en-cphi.cn
March 27, 2017
CO2RE Intima Now First In-Office Laser Procedure CE Marked for the Treatment of Vaginal Atrophy and Rejuvenation